ENVERIC BIOSCIENCES INC's ticker is and the CUSIP is 29405E208. A total of 16 filers reported holding ENVERIC BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,171 | -41.6% | 11,455 | -6.7% | 0.00% | – |
| Q1 2024 | $12,277 | -25.5% | 12,277 | -3.1% | 0.00% | – |
| Q4 2023 | $16,476 | -28.0% | 12,674 | +31.7% | 0.00% | -100.0% |
| Q3 2023 | $22,898 | -18.4% | 9,621 | +15.5% | 0.00% | 0.0% |
| Q2 2023 | $28,062 | +116825.0% | 8,327 | -41.1% | 0.00% | 0.0% |
| Q1 2023 | $24 | +14.3% | 14,129 | +43.9% | 0.00% | 0.0% |
| Q4 2022 | $21 | -99.9% | 9,817 | +28.2% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | – | 7,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 100,429 | $338,446 | 0.10% |
| Tower Research Capital LLC (TRC) | 8,327 | $28,062 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 101 | $340 | 0.00% |
| WELLS FARGO & COMPANY/MN | 30 | $101 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 54 | $182 | 0.00% |
| BlackRock Inc. | 29,578 | $99,678 | 0.00% |
| Citadel Advisors | 13,933 | $46,954 | 0.00% |
| MORGAN STANLEY | 1 | $3 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 4,559 | $15 | 0.00% |